Skip to content

Phadebact Monoclonal GC Test

by Pharmacia, Inc.

510(k) K850351

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK850351 Date13 Mar 1985ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
LIC
Device Class
Class II
Regulation
21 CFR Part 866.3390
Advisory Committee
Microbiology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Phadebact Monoclonal GC Test is an antiserum-based coagglutination (direct) test for Neisseria gonorrhoeae. It is classified as a Class II medical device under regulation number 866.3390 and falls within the microbiology specialty.

The device received traditional 510(k) clearance (K850351) from the FDA on March 13, 1985, following a 44-day review. It is manufactured by Pharmacia, Inc. and is intended for use in microbiology laboratories for the identification of Neisseria gonorrhoeae.

Other devices from Pharmacia, Inc.

See all devices from Pharmacia, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Phadebact Monoclonal GC Test used for?

    The Phadebact Monoclonal GC Test is used for the identification of Neisseria gonorrhoeae in microbiology laboratories. It is an antiserum-based coagglutination (direct) test designed specifically for this purpose, as stated in the device description.

  • How is the Phadebact Monoclonal GC Test supplied and what is its intended use setting?

    The test is supplied as an antiserum-based coagglutination reagent intended for use in microbiology laboratories. It is designed for laboratory professionals to identify Neisseria gonorrhoeae from clinical specimens, not for point-of-care or over-the-counter use.

  • Is the Phadebact Monoclonal GC Test a single-use or reusable device?

    The Phadebact Monoclonal GC Test is a single-use in vitro diagnostic reagent. As an antiserum-based test, it is consumed during the agglutination reaction and cannot be reused, which is standard for such microbiological identification reagents.